Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis

Chest

Volumn 140, Issue 1, 2011, Pages 178-185

  Loeve, Martine ^a,b   Gerbrands, Krista ^a   Hop, Wim C ^b   Rosenfeld, Margaret ^c   Hartmann, Ieneke C ^b   Tiddens, Harm A ^a,b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRONCHIECTASIS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SPIROMETRY;

EID: 79960412250     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-1152     Document Type: Article

References (36)

1. Rosenfeld M. An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all. Proc Am Thorac Soc. 2007;4(4):299-301. (Pubitemid 47330859)
2. Davis SD, Brody AS, Emond MJ, Brumback LC, Rosenfeld M. Endpoints for clinical trials in young children with cystic fibrosis. Proc Am Thorac Soc. 2007;4(4):418-430. (Pubitemid 47333916)
3. Mayer-Hamblett N, Ramsey BW, Kronmal RA. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc Am Thorac Soc. 2007;4(4):370-377. (Pubitemid 47330874)
4. Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr. 1994;124(2):177-192. (Pubitemid 24057781)
5. Que C, Cullinan P, Geddes D. Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax. 2006;61(2):155-157. (Pubitemid 43235433)
6. Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol. 2002;34(3):228-231. (Pubitemid 34971078)
7. Hansell DM. Bronchiectasis. Radiol Clin North Am. 1998;36(1):107-128. (Pubitemid 28079678)
8. de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax. 2006;61(1):80-85. (Pubitemid 43106983)
9. Robinson TE, Leung AN, Northway WH, et al. Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis. J Pediatr. 2001;138(4):553-559. (Pubitemid 32319730)
10. Tiddens HA, de Jong PA. Imaging and clinical trials in cystic fibrosis. Proc Am Thorac Soc. 2007;4(4):343-346. (Pubitemid 47330868)
11. Brody AS, Sucharew H, Campbell JD, et al. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med. 2005;172(9):1128-1132. (Pubitemid 43066648)
12. Rosenfeld M, Emerson J, Williams-Warren J, et al. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr. 2001;139(3):359-365. (Pubitemid 32889511)
13. Ortiz JR, Neuzil KM, Victor JC, Wald A, Aitken ML, Goss CH. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest. 2010;137(4):852-860.
14. Sanders DB, Hoffman LR, Emerson J, et al. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol. 2010;45(2):127-134.
15. Jones D, Shrimpton P. Survey of CT Practice in the UK. Part 3: Normalised Organ Doses for X-ray Computed Tomography Using Monte Carlo Techniques. NRPB-R250. London, England: HMSO, 1991.
16. Khursheed A, Hillier MC, Shrimpton PC, Wall BF. Influence of patient age on normalized effective doses calculated for CT examinations. Br J Radiol. 2002;75(898):819-830. (Pubitemid 35252009)
17. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr. 2004;145(1):32-38. (Pubitemid 38962449)
18. Loeve M, Lequin MH, de Bruijne M, et al. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease? Radiology. 2009;253(1):223-229.
19. Zapletal A, Paul T, Samanek M. Significance of contemporary methods of lung function testing for the detection of airway obstruction in children and adolescents [in German]. Z Erkr Atmungsorgane 1977;149:343-371. (Pubitemid 8264588)
20. New drug, antibiotic and biological drug product regulations: accelerated approval. Proposed rule. Fed Regist. 1992;57:13234-13242.
21. Katz R. Biomarkers and surrogate markers: an FDA perspective. NeuroRx. 2004;1(2):189-195. (Pubitemid 46604746)
22. Redding GJ. Bronchiectasis in children. Pediatr Clin North Am. 2009;56(1):157-171.
23. Wedzicha JA, Hurst JR. Structural and functional co-conspirators in chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc. 2007;4(8):602-605. (Pubitemid 350291621)
24. Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax. 2007;62(4):360-367. (Pubitemid 46580580)
25. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153(4):345-352. (Pubitemid 32144560)
26. Long FR, Williams RS, Castile RG. Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr. 2004;144(2):154-161. (Pubitemid 38869388)
27. Loeve M, van Hal PT, Robinson P, et al. The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax. 2009;64(10):876-882.
28. Courtney JM, Kelly MG, Watt A, et al. Quality of life and inflammation in exacerbations of bronchiectasis. Chron Respir Dis. 2008;5(3):161-168.
29. Jung KJ, Lee KS, Kim SY, Kim TS, Pyeun YS, Lee JY. Low-dose, volumetric helical CT: image quality, radiation dose, and usefulness for evaluation of bronchiectasis. Invest Radiol. 2000;35(9):557-563.
30. Brody AS, Frush DP, Huda W, Brent RL; American Academy of Pediatrics Section on Radiology. Radiation risk to children from computed tomography. Pediatrics. 2007;120(3):677-682.
31. Altes TA, Eichinger M, Puderbach M. Magnetic resonance imaging of the lung in cystic fibrosis. Proc Am Thorac Soc. 2007;4(4):321-327. (Pubitemid 47330864)
32. Failo R, Wielopolski PA, Tiddens HA, Hop WC, Mucelli RP, Lequin MH. Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med. 2009;61(2):299-306.
33. Kozlowska WJ, Bush A, Wade A, et al; London Cystic Fibrosis Collaboration. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med. 2008;178(1):42-49. (Pubitemid 351919192)
34. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A. Multiple-breath inert gas washout and spirometry versus struc tural lung disease in cystic fibrosis. Thorax. 2008;63(2):129-134. (Pubitemid 351236476)
35. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968. (Pubitemid 41632054)
36. de Jong PA, Tiddens HA. Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc. 2007;4(4):338-342. (Pubitemid 47330867)